嘉实上证科创板生物医药ETF(588700)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
22,828.50 |
28,549.56 |
1,378.72 |
| 存出保证金 |
16,603.09 |
8,254.82 |
194,050.51 |
| 交易性金融资产 |
203,304,580.66 |
301,659,435.91 |
75,906,956.73 |
| 其中：股票投资 |
203,304,580.66 |
301,659,435.91 |
75,906,956.73 |
| 债券投资 |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
588,517.73 |
- |
52,595.94 |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
- |
- |
| 应收申购款 |
- |
- |
- |
| 其他资产 |
- |
- |
- |
| 资产总计 |
204,851,207.43 |
303,535,147.03 |
76,601,681.20 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
- |
- |
- |
| 应付赎回款 |
- |
- |
- |
| 应付管理人报酬 |
91,319.35 |
135,142.33 |
31,284.03 |
| 应付托管费 |
18,263.87 |
27,028.48 |
6,256.80 |
| 应付销售服务费 |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
1.55 |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
77,298.07 |
145,834.21 |
95,264.83 |
| 负债合计 |
186,881.29 |
308,006.57 |
132,805.66 |
| 所有者权益 |
| 实收基金 |
200,336,178.00 |
365,336,178.00 |
95,336,178.00 |
| 未分配利润 |
4,328,148.14 |
-62,109,037.54 |
-18,867,302.46 |
| 所有者权益合计 |
204,664,326.14 |
303,227,140.46 |
76,468,875.54 |
| 负债及所有者权益总计 |
204,851,207.43 |
303,535,147.03 |
76,601,681.20 |
微信公众号
证券之星APP
基本资料
